Wellness Market News: Formula Fails Standards, CarnoSyn Trademark Infringement Alleged, More
Executive Summary
Former FDA chief Kessler heads CSPI board; CRN-supported Rose Awards go to Ross, Das; Bobbie Baby infant formula fails FDA standards; CRN launches Retailer Relations Forum; and NAI alleges CarnoSyn trademark infringement by Vitalize.
You may also be interested in...
Else Nutrition Takes 'Clean Label' Into Infant Formula, Toddler Beverage Market
Else Nutrition will be one of the first companies to market baby and toddler formula and a children’s beverage without dairy or soy while containing a few core ingredients, says CEO Hamutal Yitzhak. Products will debut in North America and Europe in 2020.
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.